https://www.zacks.com/stock/news/2238002/are-investors-undervaluing-norsk-hydro-asa-nhydy-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2238002
Mar 08, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:5772202280431698927
0
https://www.fool.com/investing/2024/03/07/1-wall-street-analyst-69-upside-nio-stock-buy/?source=iedfolrf0000001
Mar 07, 2024 - Nio expects its sales momentum and margins to pick up pace as 2024 progresses.
0
fool:5816082238883201531
0
https://www.wired.com/story/best-apple-tv-plus-movies/
Mar 07, 2024 - From Napoleon to Mad Max: Fury Road, here’s everything you should be watching on Apple’s streaming service.
wr:5126390813721919595
0
https://www.zacks.com/stock/news/2237573/here-s-why-docusign-docu-stock-is-a-great-pick-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237573
Mar 07, 2024 - DocuSign (DOCU) focuses on product innovation, omnichannel go-to market, and financial and operational efficiency.
zc:-5197844619846898284
0
https://www.zacks.com/stock/news/2237560/cognizant-ctsh-microsoft-team-up-to-streamline-healthcare?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2237560
Mar 07, 2024 - Cognizant (CTSH) and Microsoft join forces to transform healthcare admin with generative AI integration on TriZetto.
zc:3087254526657206373
0
https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551
Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
zc:-4688381384700326572
0
https://www.zacks.com/stock/news/2237500/iii-or-it-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2237500
Mar 07, 2024 - III vs. IT: Which Stock Is the Better Value Option?
zc:1953285218222801617
0
https://www.zacks.com/stock/news/2237503/bap-or-ry-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2237503
Mar 07, 2024 - BAP vs. RY: Which Stock Is the Better Value Option?
zc:347415722556402932
0
https://www.zacks.com/stock/news/2237411/reasons-to-retain-inari-medical-nari-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237411
Mar 07, 2024 - Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, its dependency on the adoption of products is a concern.
zc:782023971058413067
0
https://www.zacks.com/stock/news/2237409/here-s-why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237409
Mar 07, 2024 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
zc:3852916027723688889
0